BMRN vs KSS · P/E 40, rev $1.76B vs P/E 6.5, rev $6.68B
Biomarin Pharmaceutical Inc (BMRN) versus Kohl's Corporation (KSS) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Kohl's Corporation (KSS) is a department stores company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported KSS revenue for 2026-08-01 was $6.68B. Net income was $137.0M. KSS currently screens at market cap $1.74B and trailing P/E 6.5.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. KSS currently screens at market cap $1.74B and trailing P/E 6.5.
Not investment advice. Open the BMRN and KSS stock pages for the full models.
Not investment advice.